Table 4.
Joint impact of age, sex, and apparent treatment resistant hypertension on cardiovascular disease and coronary heart disease risk
|
|
Sex
|
Age
|
HR
|
(95%CI)
|
| Risk for CVD | ||||
| aTRH | ||||
| No | Female | < 65 | Reference | |
| No | Male | < 65 | 1.55 | (1.43-1.67) |
| No | Female | 65+ | 1.68 | (1.56-1.79) |
| No | Male | 65+ | 1.95 | 1.70-2.20) |
| Yes | Male | 65+ | 1.85 | (1.22-2.48) |
| Yes | Female | < 65 | 1.88 | (1.64-2.11) |
| Yes | Male | < 65 | 2.17 | (1.76-2.58) |
| Yes | Female | 65+ | 2.61 | (2.20-3.01) |
| Three-way interaction of sex, age, and aTRH on CVD, P = 0.2841 | ||||
| Risk for CHD | ||||
| aTRH | ||||
| No | Female | < 65 | Reference | |
| No | Male | < 65 | 1.72 | (1.57-1.86) |
| No | Female | 65+ | 1.59 | (1.44-1.74) |
| No | Male | 65+ | 2.1 | (1.77-2.42) |
| Yes | Male | 65+ | 2.12 | (1.28-2.97) |
| Yes | Female | < 65 | 1.79 | (1.47-2.11) |
| Yes | Male | < 65 | 2.37 | (1.82-2.92) |
| Yes | Female | 65+ | 2.53 | (1.98-3.08) |
| Three-way interaction of sex, age, and aTRH on CHD, P = 0.4246 | ||||
CVD: Cardiovascular disease; HR: Hazards ratio; aTRH: Apparent treatment resistant hypertension; CHD: Coronary heart disease.